ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "end-stage renal disease"

  • Abstract Number: 0769 • ACR Convergence 2021

    Renal Outcomes in 1528 Childhood-onset Systemic Lupus Erythematosus Patients: A Brazilian Multicenter Study

    Ana Paula Sakamoto1, Clovis Silva2, Aline Islabão3, Glaucia Novak2, Beatriz Molinari2, Rosa Pereira4, Claudia Saad-Magalhães5, Gleice Clemente6, Daniela Petry Pioto7, Nadia Aikawa4, Ana Pita2, Vitor Trindade2, Simone Appenzeller8, Luciana Carvalho9, Carlos Rabelo-Junior10, Adriana Fonseca11, Flavio Sztajnbok12, Maria Santos13, Blanca Elena Rios Gomes Bica14, Evaldo Sena15, Ana Moraes16, Melissa Fraga6, Teresa Robazzi17, Paulo Spelling18, Iloite Scheibel19, Andre Cavalcanti20, Erica Matos21, Luciano Guimarães22, Flavia Santos23, Licia Maria Henrique Mota24, Eloisa Bonfá4 and Maria Terreri25, 1Federal University of So Paulo (UNIFESP), São Paulo, Brazil, 2Pediatric Rheumatology Unit, Children’s Institute, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 3Pediatric Rheumatology Unit, Hospital da Criança de Brasília Jose Alencar, Brasilia, DF, Brazil, 4Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 5Pediatric Rheumatology Division, São Paulo State University (UNESP) – Faculdade de Medicina de Botucatu, Botucatu, Botucatu, Brazil, 6Universidade Federal de São Paulo, São Paulo, Brazil, 7Pediatric Rheumatology Unit, Universidade Federal de São Paulo, São Paulo, SP, Brazil, 8Hospital das Clínicas da Universidade Estadual de Campinas, Campinas, Brazil, 9Pediatric Rheumatology Unit, Ribeirão Preto Medical School – University of São Paulo, Ribeirão Preto, SP, Brazil, 10Pediatric Rheumatology Unit, Hospital Geral de Fortaleza, Fortaleza, CE, Brazil, 11Pediatric Rheumatology Unit, Rio de Janeiro Federal University (IPPMG-UFRJ), Rio de Janeiro, RJ, Brazil, 12UFRJ/UERJ, Rio de Janeiro, Brazil, 13Pediatric Rheumatology Unit, Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brazil, 14Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, 15Pediatric Rheumatology Unit, Lauro Vanderley University Hospital, João Pessoa, PB, Brazil, 16Pediatric Rheumatology Unit, Federal University of Pará, Belém, PA, Brazil, 17Pediatric Rheumatology Unit, Federal University of Bahia, Salvador, BA, Brazil, 18Pediatric Rheumatology Unit, Hospital Evangélico de Curitiba, Curitiba, PR, Brazil, 19Pediatric Rheumatology Unit, Hospital Criança Conceição, Porto Alegre, RS, Brazil, 20Pediatric Rheumatology Unit, Federal University of Pernambuco, Recife, PE, Brazil, 21Pediatric Rheumatology Unit, Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil, 22Pediatric Rheumatology Unit, University of Brasília, Brasilia, DF, Brazil, 23Pediatric Rheumatology Unit, Federal University of Minas Gerais, Belo Horizonte, Belo Horizonte, MG, Brazil, 24Universidade de Brasília, Brasilia, Brazil, 25UNIFESP, São Paulo, Brazil

    Background/Purpose: Lupus nephritis is a frequent manifestation in childhood-onset systemic lupus erythematosus (cSLE) and has a great potential for chronic kidney disease (CKD), requiring dialysis…
  • Abstract Number: 0954 • ACR Convergence 2021

    The Association of Rituximab- vs. Cyclophosphamide-Based Remission Induction Strategies with Risk of End-Stage Renal Disease and Death in ANCA-Associated Vasculitis

    Zachary Wallace1, Xiaoqing Fu2, Claire Cook3, Yuqing Zhang4, John Stone5 and Hyon K. Choi6, 1Massachusetts General Hospital, Newton, MA, 2Massachusetts General Hospital, Boston, MA, 3Division of Rheumatology, Allergy, and Immunology, Mass General Hospital, Boston, MA, 4Division of Rheumatology, Allergy, and Immunology, Mass General Hospital, Harvard Medical School, Boston, MA, 5Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 6Massachusetts General Hospital, Lexington, MA

    Background/Purpose: The RAVE trial established the non-inferiority of rituximab (RTX) vs cyclophosphamide (CYC) for remission induction of ANCA-Associated Vasculitis (AAV). Patients in RAVE were followed…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences